Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The studies included various experimental designs, such as randomized controlled trials, retrospective cohort studies, and preclinical animal models
In individuals with congenital hyperinsulinism due to inactivating mutations in the genes encoding the beta cell K ATP channels, the GLP-1 receptor antagonist, exendin-(9-39), increases fasting plasma glucose and prevents protein-induced hypoglycemia
GLP-1 agonists may exacerbate the muscle strength decline associated with sarcopenia, an age-related condition characterized by loss of muscle mass, strength, and function, thereby compromising balance, increasing fall risk, and eroding independence
Hydration status significantly impacts nausea severity
(PDF 2898 kb) Rights and permissions This work is licensed under a Creative Commons Attribution 4.0 International License
US$ 23.12
US$ 24.08
US$ 21.88
US$ 23.15
US$ 23.38
